Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Crohn's Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT02574637
What this trial is testing

Evaluation of Efficacy and Safety of Brazikumab (MEDI2070) in Participants With Active, Moderate to Severe Crohn's Disease

Who this might be right for
Crohn's Disease
AstraZeneca 29
Large-scale testing (Phase 3)Study completedNCT03357471
What this trial is testing

Study to Test the Safe and Effective Use of an e-Device for the Self-injection of Certolizumab Pegol Solution by Subjects With Moderate to Severe Active Rheumatoid Arthritis, Active Ankylosing Spondylitis, Active Psoriatic Arthritis, or Moderately to Severely Active Crohn's Disease

Who this might be right for
Moderate and Severe Active Rheumatoid ArthritisActive Psoriatic ArthritisActive Ankylosing Spondylitis+1 more
UCB Biopharma S.P.R.L. 70
Testing effectiveness (Phase 2)Ended earlyNCT02405442
What this trial is testing

Safety and Efficacy of Andecaliximab in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Gilead Sciences 187
Large-scale testing (Phase 3)Ended earlyNCT02403323
What this trial is testing

Open-Label Extension and Safety Study for Participants With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144

Who this might be right for
Crohn Disease
Hoffmann-La Roche 790
Post-approval studies (Phase 4)Not Yet RecruitingNCT07659353
What this trial is testing

Efficacy of Top-down Therapy With Mirikizumab Versus Standard of Care With Azathioprine in Patients With Newly Diagnosed, Moderate-to-severe Crohn's Disease

Who this might be right for
Chrohn's Disease
University Hospital Schleswig-Holstein 320
Testing effectiveness (Phase 2)Ended earlyNCT01009281
What this trial is testing

An Open Label Safety and Tolerability Study of AIN457 in Patients With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn's DiseaseInflammatory Bowel Disease
Novartis Pharmaceuticals 7
Testing effectiveness (Phase 2)Study completedNCT02015793
What this trial is testing

Study to Evaluate the Pharmacokinetics, Safety and Efficacy of Two Treatment Modules in Chinese Subjects With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn's Disease
AbbVie 30
Testing effectiveness (Phase 2)Study completedNCT05499130
What this trial is testing

Test the Effect of TEV-48574 in Moderate to Severe Ulcerative Colitis or Crohn's Disease

Who this might be right for
Crohn DiseaseColitis, Ulcerative
Teva Branded Pharmaceutical Products R&D, Inc. 290
Large-scale testing (Phase 3)Study completedNCT00162942
What this trial is testing

Study for the Treatment of Crohn's Disease With Adacolumn

Who this might be right for
Crohn's Disease
Otsuka America Pharmaceutical 235
Early research (Phase 1)Ended earlyNCT03478956
What this trial is testing

A Phase I Study of Etrolizumab Followed by Open-Label Extension and Safety Monitoring in Pediatric Patients With Moderate to Severe Ulcerative Colitis or Moderate to Severe Crohn's Disease

Who this might be right for
Ulcerative ColitisCrohn's Disease
Hoffmann-La Roche 24
Testing effectiveness (Phase 2)Study completedNCT01696396
What this trial is testing

Abrilumab (AMG 181) in Adults With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn's Disease
Amgen 254
Testing effectiveness (Phase 2)Active Not RecruitingNCT06450197
What this trial is testing

Phase IIa Study Evaluating AZD7798 in Crohn's Disease

Who this might be right for
Moderate to Severe Crohn's Disease
AstraZeneca 120
Large-scale testing (Phase 3)Study completedNCT03105128
What this trial is testing

The Efficacy and Safety of Risankizumab in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
AbbVie 931
Not applicableStudy completedNCT03488030
What this trial is testing

Evaluate Disease Control, Treatment Patterns, Burden of Disease and Quality of Life in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD)

Who this might be right for
Crohn DiseaseColitis, UlcerativeInflammatory Bowel Disease
Takeda 246
Not applicableLooking for participantsNCT05428345
What this trial is testing

Vedolizumab SC Given to Adults With Moderate to Severe Ulcerative Colitis or Crohn's Disease in South Korea

Who this might be right for
Ulcerative ColitisCrohn's DiseaseInflammatory Bowel Disease (IBD)
Takeda 600
Testing effectiveness (Phase 2)UnknownNCT02465944
What this trial is testing

A Pilot Study of FFP104 in Subjects With Crohn's Disease

Who this might be right for
Crohn's Disease
Fast Forward Pharmaceuticals 24
Testing effectiveness (Phase 2)Study completedNCT01466374
What this trial is testing

Induction and Maintenance Study of BMS-936557 in Patients With Moderate to Severely Active Crohn's Disease

Who this might be right for
Crohn's Disease
Bristol-Myers Squibb 121
Testing effectiveness (Phase 2)Ended earlyNCT01150890
What this trial is testing

Brodalumab (AMG 827) in Adults With Moderate to Severe Crohn's Disease

Who this might be right for
Crohn's Disease
Amgen 130
Large-scale testing (Phase 3)Study completedNCT03345849
What this trial is testing

The Efficacy and Safety of Upadacitinib in Participants With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional and/or Biologic Therapies

Who this might be right for
Crohn's Disease
AbbVie 526
Large-scale testing (Phase 3)Looking for participantsNCT07196722
What this trial is testing

Icotrokinra in Participants With Moderately to Severely Active Crohn's Disease

Who this might be right for
Crohn Disease
Janssen Research & Development, LLC 1,092
Next Page